³Ñ²½¾É¡¦±ê¾ÉÀ­³Ñ²½¾É

[ ¥ê¥¹¥È | ¾ÜºÙ ]

µ­»ö¸¡º÷
¸¡º÷

Á´2¥Ú¡¼¥¸

[1] [2]

[ ¼¡¤Î¥Ú¡¼¥¸ ]

٨ʿÂÝáý LP:lichen planus

[Î×¾²Áü]lichen(¥®¥ê¥·¥ã¸ìleichen)¤Ï¥³¥±¤ò°ÕÌ£¤·¡¢¼ê´ØÀᡦ»Í»è¤Î¶þ¶Ê¦¡¢µÓ¡¢Âδ´¡¢±¢·Ô¡¢¸ý¹Ð¡¢çµÇ´Ëì¤Ë³¥ÀÄ¿§¡Á»ç¹È¿§¤Î¤«¤æ¤ß¤òȼ¤¦µÖ¿¾¤Ê¤¤¤·¶ÉÌ̤òǧ¤áɽÌ̤ÏϹÍ͸÷Âô¤ò¼¨¤¹¡£¤Þ¤ì¤Ë¿åáפ¬¤Ç¤­¤ë¤³¤È¤¬¤¢¤ë(bullous LP)¡£30-60ºÐ¤Ëȯ¾É¤·¤ä¤¹¤¤¤¬¾®»ùÎã¤â¿ô%¤¢¤ë¡£30-70¡ó¤Ë¸ý¹ÐÇ´Ë쿾¤ò¹çÊ»¤·ËËÇ´Ëì¤ËÌÖ¾õ¤ËÇÛÎ󤹤ëÇò¿§Àþ¾ò¤òǧ¤á¤ë¡£¸ý¿°Ç´Ëì¤ÎÈ鿾¤ÏÍ­ÛùºÙ˦´â¤Ø°Ü¹Ô¤¹¤ë(0.3-3%¤ÈÊó¹ð¤µ¤ì¤Æ¤¤¤ë)¤³¤È¤â¤¢¤ë(ÆÃ¤ËÃËÀ­)¤Î¤ÇÃí°Õ¤¹¤ë¡£10¡ó¤ËÄÞÉÂÊѤòǧ¤á¤ë¡£µÖ¿¾¤¬ÈéÉæ¤Î»½ýÉô°Ì¤Ë¤ß¤é¤ì¤ë¤³¤È¤¬¤¢¤ë¡Ê¥±¥Ö¥Í¥ë¸½¾É¡Ë¡£Â¿¤¯¤Î¿Í¤Ï18¥ö·î°ÊÆâ¤Ë¼£Ìþ¤¹¤ë¡£¥ª¥ê¡¼¥ÖÌý¤Ê¤É¤òÈ鿾¤Ë¤¿¤é¤¹¤ÈºÙ¤¤Çò¿§Àþ¾ò¤¬´Ñ»¡¤Ç¤­¤ë¡ÊWickhamÀþ¾ò¡Ë¡£É°ø¤ÏÉÔÌÀ¤Ç¤¢¤ë¤¬¡¢ÌôºÞ(٨ʿÂÝáý·¿Ìô¿¾)¡¢¶â°¥¢¥ì¥ë¥®¡¼(»õ²Ê¶â°¤¬Àܤ·¤Æ¤¤¤ëÉôʬ¤ËÉÂÊѤ¬¤¢¤ë¤È¤­¤Ï¥Ñ¥Ã¥Á¥Æ¥¹¥È¤ò¹Ô¤Ã¤¿¤Û¤¦¤¬Îɤ¤)¡¢¸¶È¯À­ÃÀ½ÁÀ­´Î¹ÅÊÑ¡¢¥¢¥ë¥³¡¼¥ëÀ­´Î¹ÅÊÑ¡¢ç±¸¶É¡¢ÅüÂå¼Õ°Û¾ï¡¢HCV¤È¤Î¹çÊ»¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤ë¡£°ÊÁ°¤Ï¥«¥é¡¼¥Õ¥£¥ë¥à¸½Áü±ÕÃæ¤Î¥Ñ¥é¥Õ¥§¥Ë¥ë¥¸¥¢¥ß¥ó¤Ë¤è¤êͶȯ¤µ¤ì¤¿¾ÉÎ㤬¿¤«¤Ã¤¿¤¬¡¢¸½ºß¤Ïµ¡³£²½¤µ¤ì¤¿¤¿¤á¤Û¤È¤ó¤É¤ß¤é¤ì¤Ê¤¤¡£
[ÉÂÍý]ɽÈéðùγÁؤÎÈî¸ü(wedge-shaped hypergranulosis Wickham striae¤ËÁêÅö)¡¢É½ÈéÆÍµ¯¤Îµø»õ¾õ±äĹ(sawtooth-shape rete ridge)¡¢²õ»à¥±¥é¥Á¥Î¥µ¥¤¥È(Civatte body)¤òǧ¤á¤ë¡£¿¿Èé¾åÁؤˤÏÂÓ¾õ¤Î¥ê¥ó¥Ñµå¿»½á(band-like lymphocytic infiltration)¡£´ðÄìÁؤζõ˦ÊÑÀ­¤òǧ¤á¡¢»þ¤ËɽÈ顦¿¿Èé¶­³¦Éô¤ÎÎö·ä·ÁÀ®(Max-Joseph space)¤òÀ¸¤¸¤ë¡£

³«¤¯ ¥È¥é¥Ã¥¯¥Ð¥Ã¥¯¡Ê5¡Ë

[Î×¾²Áü]¼ê»ØÇØ¡¢»Í»è¿­Â¦¡¢¶»Ê¢Éô¤ËĬ¹È¤òȼ¤¦ÌÓ¹¦À­³Ñ²½À­µÖ¿¾¡¢¾¸í¨¤Î³Ñ²½À­¹ÈÈäòÆÃħ¤È¤¹¤ë¼À´µ¡£»þ¤ËÈ鿾¤¬³ÈÂ礷¹ÈÈþɲ½¤¹¤ë¤³¤È¤¬¤¢¤ë¡£²¼µ­¤Î¤è¤¦¤ËʬÎव¤ì¤Æ¤¤¤ë¡£­µ·¿¤Ï50Âå¤Ë¿¤¯È¯¾É¤·¡¢ÈïȱƬÉô¡¢´éÌÌ¡¢¾åȾ¿È¤Î»éϳÉô°Ì¤Ëäã¹ÇÍÍÍî¶ýÀ­¹ÈÈäȤ·¤ÆÈ¯¾É¡¢¤½¤Î¿ô½µ´Ö¸å¤ËÌÓ¹¦°ìÃ×À­¤Î³Ñ²½À­µÖ¿¾¤òÀ¸¤¸¡¢¾¸í¨¤Ë³Ñ²½À­µÖ¿¾¤òÀ¸¤¸¤ë¡£¤½¤Î¸å¡¢µÖ¿¾¤ÏÌþ¹ç¤·¤·¤Ð¤·¤Ð¹ÈÈé¾É¾õÂ֤˿ÊŸ¤¹¤ë¡£ºÇ¶á¤Ç¤ÏHIV´ØÏ¢¤Î¥¿¥¤¥×¤¬6·¿ÌܤÎÉ·¿¤È¤·¤ÆÄ󾧤µ¤ì¤Æ¤¤¤ë¡£°­À­¼ðáç¤È¤Î¹çÊ»Î㤬Êó¹ð¤µ¤ì¤Æ¤¤¤ë¤¬¡¢Åý·×¾åÍ­°Õ¤Ë¿¤¯¤Ï¤Ê¤¤¡£É°ø¤ÏÉÔÌÀ¤Ç¤¢¤ë¤¬¾®»ù·¿¤Ï°äÅÁÀ­ÅªÇطʤ¬¼¨º¶¤µ¤ì¡¢À®¿Í·¿¤ÏÆâʬÈç°Û¾ïÀâ¡¢´Îµ¡Ç½°Û¾ïÀâ¡¢ÃæÆÇÀâ¡¢°­À­¼ðáçÀâ¡¢¥Ó¥¿¥ß¥óA·ç˳Àâ¡¢´¶À÷¾ÉÀâ¤Ê¤É¤¬»ØÅ¦¤µ¤ì¤Æ¤¤¤ë¡£

Griffiths classification
·¿È¯¾ÉΨ3ǯ°ÊÆâ¤Î´²²òΨÎ×¾²ÅªÆÃħ
­µ·¿¡¡À®¿Í·¿55% 81%Ͷ°øÌµ¤¯µÞÀ­¤Ëȯ¾É¡¢»þ¤ËÁßáÚ´¶Í­¤ê¡¢ÌóȾ¿ô¤Ë¹ÈÈé¾É¤òǧ¤á¤ë
­¶·¿¡¡À®¿ÍÈóÄê·¿·¿5%20% Ť¤·Ð²á¤ò¼è¤ë¡Ê20ǯ°Ê¾å¤«¤«¤ë¤È¤­¤â¤¢¤ê¡Ë¡£µûÎÚáýÍÍÍî¶ý¡¦¼¾¿¾¶ÉÌÌ¡¦Ã¦ÌÓÈÃ
­··¿¡¡ÍÄ»ùÄê·¿10%16%2ºÐ̤Ëþ¤Ëȯ¾É¡¢­µ·¿¤ÈÎ×¾²Áü¤ÏƱ¤¸¡¢¤¿¤À¤·È鿾¾ÃÂà¤ÏÁ᤯ʿ¶Ñ1Ç¯ÄøÅÙ¡£
­¸·¿¡¡ÍÄ»ù¸Â¶É·¿25%32%12ºÐ̤Ëþ¤Ëȯ¾É¡¢¹ÈÈÃÀ­³Ñ²½À­¶ÉÌ̤ϸ¶ɡ¢¿Ê¹Ô¤Ï¤Þ¤ì
­¹·¿¡¡ÍÄ»ùÈóÄê·¿5%0%2-3ºÐ¤Ëȯ¾Éޤ³Ñ²½¡ä¹ÈÈᢼ꾸¤Î¶¯Èé¾ÉÍÍÊѲ½¡¢²È²Æâȯ¾É¤ÎÎ㤬¿¤¤
­º·¿¡¡HIV´ØÏ¢·¿ HIV¤Ëȼ¤¤Ä̾ï¤Î¼£ÎŤËÄñ¹³¤¹¤ë¤¬HIV¼£ÎÅÌô¤ËÈ¿±þ¤¹¤ë¡£
[¼£ÎÅ]¥¨¥È¥ì¥Á¥Ê¡¼¥ÈÆâÉþ¡¢¥¹¥Æ¥í¥¤¥É³°ÍÑ¡¢¥Ó¥¿¥ß¥óD3Æð¹Ñ³°ÍѤòÃæ¿´¤Ë¹Ô¤ï¤ì¤Æ¤¤¤ë¡£

³«¤¯ ¥È¥é¥Ã¥¯¥Ð¥Ã¥¯¡Ê3¡Ë

Àþ¾õÂÝáý Lichen striatus

[Î×¾²Áü]10ºÐ°Ê²¼¤Î½÷»ù¤Î»Í»è¤Ë¹¥È¯¤·¡¢Ìþ¹ç·¹¸þ¤ò¼¨¤¹Ã¸¹È¿§¤«¤é°ÅÀÖ¿§¤ÎµÖ¿¾¤¬Éý1-2cm¤ÇÊÒ¦À­Ž¤ÂÓ¾õ¤ËÇÛÎ󤹤ë¼À´µ¡£¤Þ¤ì¤Ëξ¦À­¤È¤Ê¤êޤÈ鿾±äĹ¾å¤Î¤Ä¤áÇ˲õ¤òȼ¤¦¤³¤È¤¬¤¢¤ë¡£È鿾¤ÏBlaschkoÀþ¤Ë°ìÃפ¹¤ë¤ÈÊó¹ð¤µ¤ì¤Æ¤¤¤ë¡£´éÌÌȯ¾É¤Ï3%ÄøÅ٤Ȥޤ졣¥¢¥È¥Ô¡½À­ÈéÉæ±ê¤È¤Î¹çÊ»Îã¤Ï27.3%¤Û¤É¤¢¤ë¡£À®¿Í¤ËÀ¸¤¸¤¿¤È¤­¤Ë¤ÏÉÂÊѤ¬¤è¤ê¹­ÈϰϤÇÁßáÚ¤¬¤¢¤ê±ê¾ÉÈ¿±þ¤¬¶¯¤¯¿åá×·ÁÀ®¤òǧ¤á¤ë¤³¤È¤â¤¢¤ë¡£¼«³Ð¾É¾õ¤Ï¤Û¤È¤ó¤É¤Ê¤¯Â¿¤¯¤Ï¿ô¥ö·î¤ÇŤ¯¤È¤â3ǯ°ÊÆâ¤Ë¾Ãêô¤¹¤ë¡£¼£Ìþ¸å¤Î¿§ÁÇÄÀÃå¤ÏÀþ¾õ٨ʿÂÝáý¤È°Û¤Ê¤êǧ¤á¤Ê¤¤¤¬¡¢¿§ÁÇæ¼º¤òÄ褹¤ë¤³¤È¤¬¤¢¤ë¡£

³«¤¯ ¥È¥é¥Ã¥¯¥Ð¥Ã¥¯¡Ê3¡Ë

[Î×¾²Áü]È鿾¤¬ÂÓ¾õ¤Ëblaschko¡¡line¤Ë°ìÃפ·¤ÆÇÛÎ󤹤ë¼À´µ¡£Áý°­´²²ò¤ò·«¤êÊÖ¤¹¤¬Æü¸÷¡¢´¶À÷¤Ç°­²½¤¹¤ë¡£²È²Æâ¤ËƱ¾É¤òǧ¤á¤ë¡£ÉÂÍý³ØÅª¤Ë¤ÏHailey-Hailey¤ÎÁü¤Ë°ìÃפ¹¤ë¡£

³«¤¯ ¥È¥é¥Ã¥¯¥Ð¥Ã¥¯¡Ê4¡Ë

[Î×¾²Áü]1970ǯRalph W. Grover¤¬ºÇ½é¤ËÊó¹ð¤·¤¿¼À´µ¤Ç¡¢ÃæÆÀǯ°Ê¹ß¤Ë°ì²áÀ­¤ËÂ礭¤µ1-3mmÂç¤ÎÉâ¼ðÀ­µÖ¿¾¡¢¾®¿åË¢¤¬Âδ´¡¦»Í»è¶á°Ì¤ËÀ¸¤¸¤Û¤È¤ó¤É¤ÎÎã¤Ç·ã¤·¤¤¤½¤¦áÚ¤ò¤­¤¿¤¹¡£ÉÂÊѤ˸ºß¤¹¤ë¹¥»Àµå¤Î¿¤µ¤Ç¤«¤æ¤ß¤Î¶¯¤µ¤¬ÊѲ½¤¹¤ë¡£»þ¤Ë¤Ó¤é¤ó¡¢·ëáФò¤­¤¿¤·¡¢ÉÂÍýÁÈ¿¥³ØÅª¤ËÛùÍ»²ò¤ò¼¨¤¹¼À´µ¡£È鿾¤ÏÈóÌþ¹çÀ­¤Ç¡¢¹ÈÈÃÀ­¡¢Éâ¼ðÀ­¡¢¤¶áìÍÍ¡¢³Ñ²½À­¡¢¹È¿§¤«¤é³ì¿§¤ÎµÖ¿¾¤Èµ­ºÜ¤µ¤ì¤ë¤³¤È¤¬Â¿¤¤¡£°äÅÁÀ­¤Ï¤Ê¤¤¡£É½Ì̤¬¤Ê¤á¤é¤«¤Ê¤â¤Î¤Ï¿ôÆü¤Ç¾Ã¼º¤·³Ñ²½À­¤Î¤â¤Î¡ÊÉÂÍýÁü¤ÏDarier·¿¡Ë¤Ï²¿½µ¤Ë¤â¤ï¤¿¤Ã¤ÆÈ鿾¤¬»ý³¤¹¤ë¤È¤¤¤ï¤ì¤ë¡£ºÆÈ¯¤¹¤ë¤³¤È¤â¤¢¤ë¡£É°ø¤È¤·¤ÆUV¤¬trigger¤È¤Ê¤ëÎ㤬¤¢¤ë¤È¤³¤ä²¹Ç®¤ª¤è¤Óȯ´À¤Î´ØÍ¿¤¬¿ä¬¤µ¤ì¤Æ¤¤¤ë¡£¤Þ¤¿etretinate¤¬ÁÕ¸ù¤·¤¿Î㤬¤ª¤ª¤¤¤¤¤³¤È¤«¤é³Ñ²½²áÄø¤Î´ØÍ¿¤¬¼¨º¶¤µ¤ì¤Æ¤¤¤ë¡£sulfadoxinepyrimethamine(Fansidar ¹³¥Þ¥é¥ê¥¢Ìô)¡¢IL-4¼£ÎŤÇȯÀ¸¤·¤¿Î㤬¤¢¤ë¡£¤Þ¤¿ÈóÆÃ°ÛŪ¤Êáڤߤä±ê¾É¡Ê¥¢¥È¥Ô¡¼¡¢´¥Èé¾É¤Ê¤É¡Ë¤«¤éȯÀ¸¤¹¤ë¤³¤È¤â¤¢¤ë¡£°­À­¼ðáç¤Ë¹çÊ»¤·¤¿Îã¤âÊó¹ð¤µ¤ì¤Æ¤¤¤ë¤¬¶öÁ³¤Î²ÄǽÀ­¤¬¹â¤¤¡£
²¿Ç¯¤â³¤¯persistent acantholytic dermatosis¤È¿ô½µ¤«¤é¿ô¥ö·î¤Ç¼«Á³¾Ã¼º¤¹¤ëtransient acantholytic dermatosis¤¬¤¢¤ë¡£
[ÉÂÍý]²¼µ­¤Î5¤Ä¤Î¥¿¥¤¥×¤¬¤¢¤ë¤¬¹çÊ»¤¹¤ë¾ì¹ç¤â¤¢¤ë¡¡
ÍîÍÕ¾õÅ·á×áì·¿(pemphigus foliaceus-like pattern)
¥À¥ê¥¨¡¼·¿(Darier-like pattern)
¥Ø¥¤¥ê¡¼¡¦¥Ø¥¤¥ê¡¼·¿(Hailey-Haiely-like pattern)
³¤ÌʾõÂÖ¡¼ÛùÍ»²ò·¿(spongiotic acantholytic pattern)
¿Ò¾ïÀ­Å·á×áì·¿(pemphigus vulgaris-like pattern)

³«¤¯ ¥È¥é¥Ã¥¯¥Ð¥Ã¥¯¡Ê2¡Ë

Á´2¥Ú¡¼¥¸

[1] [2]

[ ¼¡¤Î¥Ú¡¼¥¸ ]


.
¥·¥ê¥¨¥È¥¯
¥·¥ê¥¨¥È¥¯
Èó¸ø³« / Èó¸ø³«
¿Íµ¤ÅÙ
Yahoo!¥Ö¥í¥°¥Ø¥ë¥× - ¥Ö¥í¥°¿Íµ¤Å٤ˤĤ¤¤Æ

²áµî¤Îµ­»ö°ìÍ÷

Æü ·î ²Ð ¿å ÌÚ ¶â ÅÚ
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
¸¡º÷ ¸¡º÷

Yahoo!¤«¤é¤Î¤ªÃΤ餻

[PR]¤ªÆÀ¾ðÊó

¿ôÎ̸ÂÄꡪ¥¤¥ª¥ó¤ª¤Þ¤È¤á´ë²è
¡Ö̵ÎÁ¤ª»î¤·¥¯¡¼¥Ý¥ó¡×¤«
¡ÖÃͰú¤­¥¯¡¼¥Ý¥ó¡×¤¬É¬¤ºÅö¤¿¤ë¡ª
¤Õ¤ë¤µ¤ÈǼÀÇ¥µ¥¤¥È¡Ø¤µ¤È¤Õ¤ë¡Ù
¼Â¼Á2000±ß¤ÇÆÃ»ºÉʤ¬¤ª¼ê¸µ¤Ë
11¡¿30¤Þ¤Ç¥­¥ã¥ó¥Ú¡¼¥ó¼Â»ÜÃæ¡ª

¤½¤Î¾¤Î¥­¥ã¥ó¥Ú¡¼¥ó


¤ß¤ó¤Ê¤Î¹¹¿·µ­»ö